BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 23 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,028 | -54.4% | 30,251 | -20.9% | 0.00% | – |
| Q2 2023 | $26,372 | -88.9% | 38,221 | +26.8% | 0.00% | – |
| Q1 2023 | $237,765 | +840.3% | 30,135 | +7.3% | 0.00% | – |
| Q4 2022 | $25,287 | -18.4% | 28,097 | 0.0% | 0.00% | – |
| Q3 2022 | $31,000 | -11.4% | 28,097 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -47.0% | 28,097 | 0.0% | 0.00% | – |
| Q1 2022 | $66,000 | -41.6% | 28,097 | -22.8% | 0.00% | – |
| Q4 2021 | $113,000 | -24.2% | 36,410 | -0.7% | 0.00% | – |
| Q3 2021 | $149,000 | -15.8% | 36,653 | +0.3% | 0.00% | – |
| Q2 2021 | $177,000 | -55.0% | 36,555 | -51.6% | 0.00% | – |
| Q1 2021 | $393,000 | -34.3% | 75,579 | -15.7% | 0.00% | – |
| Q4 2020 | $598,000 | -36.2% | 89,607 | -2.8% | 0.00% | – |
| Q3 2020 | $938,000 | -17.1% | 92,226 | +2.4% | 0.00% | – |
| Q2 2020 | $1,131,000 | – | 90,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 85,500 | $347,000 | 0.47% |
| ACT CAPITAL MANAGEMENT, LLC | 25,000 | $102,000 | 0.05% |
| TUDOR INVESTMENT CORP ET AL | 20,000 | $81,000 | 0.00% |
| Professional Financial Advisors, LLC | 500 | $2,000 | 0.00% |
| Renaissance Technologies | 201,706 | $819,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,000 | $4,000 | 0.00% |
| US BANCORP \DE\ | 1,221 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 74 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250,052 | $1,015,000 | 0.00% |
| NORTHERN TRUST CORP | 36,653 | $149,000 | 0.00% |